Your browser doesn't support javascript.
loading
Daratumumab monotherapy compared with historical control data in heavily pretreated and highly refractory patients with multiple myeloma: An adjusted treatment comparison.
Usmani, Saad Z; Diels, Joris; Ito, Tetsuro; Mehra, Maneesha; Khan, Imran; Lam, Annette.
Afiliação
  • Usmani SZ; Levine Cancer Institute/Carolinas Health Care System, Charlotte, North Carolina.
  • Diels J; Janssen Health Economics & Market Access EMEA Statistics & Modeling, Beerse, Belgium.
  • Ito T; Janssen Health Economics & Market Access EMEA, High Wycombe, UK.
  • Mehra M; Janssen Global Services, Raritan, New Jersey.
  • Khan I; Janssen Research & Development, LLC, Raritan, New Jersey.
  • Lam A; Janssen Global Services, Raritan, New Jersey.
Am J Hematol ; 92(8): E146-E152, 2017 Aug.
Article em En | MEDLINE | ID: mdl-28474745
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2017 Tipo de documento: Article